MedicineCardiologyPediatricsPediatric CardiologyPediatric PulmonologyPulmonologyCongenital Heart DiseaseInhalation AnesthesiaInhalation Drug DeliveryInhalation TherapyPulmonary HypertensionVasodilator TherapyCongenital Heart Disease PathophysiologyCongenital Valvular Heart DiseaseInhaled Nitric Oxide TherapyNitric OxidePediatric Pulmonary HypertensionPulmonary Hypertension Due To Congenital Heart DiseasePulmonary Vasodilator TherapyVasodilator Pharmacology
The use of inhaled nitric oxide as a selective pulmonary vasodilator has expanded to include patients with congenital heart disease and pulmonary hypertension. The therapeutic and diagnostic roles of inhaled nitric oxide offer additional alternatives and benefits to these patients with pulmonary hypertension, particularly in the postoperative setting. This article reviews the background, mechanism of action, toxicities, and current clinical applications of inhaled nitric oxide in the child with congenital heart disease and pulmonary hypertension.
57
Inhaled Nitric Oxide for the Adult Respiratory Distress Syndrome
Rolf Rossaint, K. J. Falke, Frank A. López et al. · New England Journal of Medicine · 1993 · 1.8K citations · Full text
Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle
Victoria M. Bolotina, Soheil Najibi, James Palacino et al. · Nature · 1994 · 1.7K citations